Levofloxacine Stada (Levofloxacin Hemihydrate)

Levofloxacin blocks two essential bacterial enzymes, DNA gyrase and topoisomerase IV, which are required for DNA replication and transcription. By inhibiting these enzymes, the drug prevents bacterial DNA from unwinding and separating, leading to bacterial cell death and eradication of the infection.

The dosage of Levofloxacine Stada is determined by the prescribing clinician based on the type and severity of the infection, patient age, renal function, and other clinical factors. Patients should follow the exact dosing instructions provided on the prescription label.

Safety data for levofloxacin in pregnancy and lactation are limited. The drug should be used only if the potential benefits justify the possible risks to the fetus or infant. Healthcare providers will assess individual circumstances before prescribing to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Levofloxacin offers a broad spectrum of activity against both Gram‑positive and Gram‑negative bacteria and has a convenient once‑daily dosing regimen for many infections. Compared with older fluoroquinolones, it often provides higher potency against respiratory pathogens and a more favorable safety profile, though class‑related risks such as tendon injury remain.

Levofloxacine Stada should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Levofloxacine Stada is taken orally, usually with a full glass of water. It can be taken with or without food, but antacids containing magnesium or aluminum should be spaced at least two hours apart to avoid reduced absorption.

Serious adverse events include tendon rupture, especially of the Achilles tendon, QT interval prolongation leading to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and peripheral neuropathy. Patients should be instructed to seek immediate medical attention if they experience sudden tendon pain, palpitations, or severe skin reactions.

Levofloxacine Stada is contraindicated in patients with a known hypersensitivity to levofloxacin or other fluoroquinolones. It should also be avoided in individuals with a history of tendon disorders related to fluoroquinolone therapy, those with significant QT prolongation, and patients receiving concomitant medications that may cause dangerous drug interactions without proper monitoring.